• CSPC Pharmaceutical Announces 2020 Interim Results prnasia
    August 26, 2020
    For the current period, the Group recorded a revenue of RMB12,590 million, an increase of 12.6% year-on-year, and profit attributable to shareholders of RMB2,314 million, an increase of 23.2% year-on-year.
PharmaSources Customer Service